Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. EXPO
stocks logo

EXPO

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
128.48M
+3.81%
0.474
+3.1%
144.47M
+5.12%
0.547
+5.15%
144.94M
+9.08%
0.578
+11.11%
Estimates Revision
The market is revising Upward the revenue expectations for Exponent, Inc. (EXPO) for FY2025, with the revenue forecasts being adjusted by 0.46% over the past three months. During the same period, the stock price has changed by 3.96%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.46%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-13.55%
In Past 3 Month
Stock Price
Go Up
up Image
+3.96%
In Past 3 Month
Wall Street analysts forecast EXPO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXPO is 76.00 USD with a low forecast of 76.00 USD and a high forecast of 76.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast EXPO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXPO is 76.00 USD with a low forecast of 76.00 USD and a high forecast of 76.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 74.250
sliders
Low
76.00
Averages
76.00
High
76.00
Current: 74.250
sliders
Low
76.00
Averages
76.00
High
76.00
William Blair
Andrew Nicholas
Market Perform -> Outperform
upgrade
2025-11-17
Reason
William Blair
Andrew Nicholas
Price Target
2025-11-17
upgrade
Market Perform -> Outperform
Reason
William Blair analyst Andrew Nicholas upgraded Exponent to Outperform from Market Perform. The firm believes strength in reactive demand, mid-single-digit headcount growth, and price realization will support the company's return to "at least" high-single-digit revenue growth in 2026. The firm also believes Exponent will be a net beneficiary of artificial intelligence in the medium term. Blair sees an attractive valuation at current levels and likes Exponent's setup over the next 12 months.
Truist
Buy
downgrade
$100 -> $90
2025-11-02
Reason
Truist
Price Target
$100 -> $90
2025-11-02
downgrade
Buy
Reason
Truist lowered the firm's price target on Exponent to $90 from $100 and keeps a Buy rating on the shares. AI could be a beneficiary to engagements for Exponent as clients turn to the company for failure analysis work, but the firm is also acknowledging the risk that efficiencies could lead to less billable hours and believes that automation will remain an overhang on the consulting industry, the analyst tells investors in a research note.
UBS
Neutral
downgrade
$84 -> $76
2025-08-01
Reason
UBS
Price Target
$84 -> $76
2025-08-01
downgrade
Neutral
Reason
UBS lowered the firm's price target on Exponent to $76 from $84 and keeps a Neutral rating on the shares.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Exponent Inc (EXPO.O) is 33.92, compared to its 5-year average forward P/E of 47.05. For a more detailed relative valuation and DCF analysis to assess Exponent Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
47.05
Current PE
33.92
Overvalued PE
55.40
Undervalued PE
38.69

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
33.20
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
39.26
Undervalued EV/EBITDA
27.13

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
9.69
Current PS
0.00
Overvalued PS
11.62
Undervalued PS
7.77
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

EXPO News & Events

Events Timeline

(ET)
2025-10-30
16:19:05
Exponent anticipates low single-digit revenue growth before reimbursements for FY25.
select
2025-10-30
16:18:30
Exponent anticipates low to mid single-digit revenue growth in Q4 prior to reimbursements.
select
2025-10-30
16:17:36
Exponent Announces Q3 EPS of 55c, Exceeding Consensus of 53c
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
12-04NASDAQ.COM
Exponent (EXPO) Stock Surpasses 200-Day Moving Average
  • 52 Week Range: EXPO's stock has a 52-week low of $63.81 and a high of $98.325, with the last trade recorded at $74.86.
  • Dividend Stocks: The article mentions a link to find 9 other dividend stocks that have recently crossed above their 200-day moving average.
  • Author's Opinion: The views expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.
  • Market Analysis: The information provided reflects a snapshot of EXPO's stock performance within the context of broader market trends.
[object Object]
Preview
9.5
10-31NASDAQ.COM
Exponent (EXPO) Surpasses Q3 Earnings and Revenue Projections

  • Earnings Performance: Exponent (EXPO) reported quarterly earnings of $0.55 per share, exceeding the Zacks Consensus Estimate of $0.50, marking a 10% earnings surprise and surpassing estimates for four consecutive quarters.

  • Revenue Growth: The company generated revenues of $137.07 million, surpassing expectations by 4.38% and showing an increase from $125.08 million year-over-year, also exceeding revenue estimates for the past four quarters.

  • Stock Outlook: Despite the positive earnings report, Exponent shares have declined by 26.6% this year, and the stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.

  • Industry Context: The Consulting Services industry, where Exponent operates, ranks in the top 39% of Zacks industries, suggesting potential for better performance compared to lower-ranked sectors, while Gartner (IT) is set to report its earnings soon.

[object Object]
Preview
8.0
10-28NASDAQ.COM
Significant Options Activity on Monday: RCL, EXPO, BURL

  • Exponent Inc. Options Trading: Exponent Inc. (EXPO) experienced a significant options trading volume of 2,677 contracts, with a notable focus on the $60 strike call option expiring June 18, 2026, which saw 1,258 contracts traded.

  • Burlington Stores Inc. Options Trading: Burlington Stores Inc. (BURL) had an options trading volume of 6,875 contracts, particularly highlighted by the $220 strike put option expiring December 05, 2025, with 3,960 contracts traded.

  • Trading Volume Comparison: The options trading volumes for both EXPO and BURL represented approximately 79.7% and 79.4% of their respective average daily trading volumes over the past month.

  • Further Information: For additional details on available expirations for RCL, EXPO, or BURL options, StockOptionsChannel.com can be visited.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Exponent Inc (EXPO) stock price today?

The current price of EXPO is 74.25 USD — it has increased 0.64 % in the last trading day.

arrow icon

What is Exponent Inc (EXPO)'s business?

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.

arrow icon

What is the price predicton of EXPO Stock?

Wall Street analysts forecast EXPO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXPO is 76.00 USD with a low forecast of 76.00 USD and a high forecast of 76.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Exponent Inc (EXPO)'s revenue for the last quarter?

Exponent Inc revenue for the last quarter amounts to 137.07M USD, increased 9.58 % YoY.

arrow icon

What is Exponent Inc (EXPO)'s earnings per share (EPS) for the last quarter?

Exponent Inc. EPS for the last quarter amounts to 0.55 USD, increased 10.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Exponent Inc (EXPO)'s fundamentals?

The market is revising Upward the revenue expectations for Exponent, Inc. (EXPO) for FY2025, with the revenue forecasts being adjusted by 0.46% over the past three months. During the same period, the stock price has changed by 3.96%.
arrow icon

How many employees does Exponent Inc (EXPO). have?

Exponent Inc (EXPO) has 1168 emplpoyees as of December 05 2025.

arrow icon

What is Exponent Inc (EXPO) market cap?

Today EXPO has the market capitalization of 3.70B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free